Results Median parathyroid hormone increased from phase 1 to phase 4 in all regions
except for Japan, where it remained stable. Prescriptions of intravenous vitamin D analogs …

Patients with chronic kidney disease (CKD) exhibit tremendously elevated risk for
cardiovascular disease, particularly ischemic heart disease, due to premature vascular and …

Objective To investigate whether calcium supplements increase the risk of cardiovascular
events. Design Patient level and trial level meta-analyses. Data sources Medline, Embase …

Chronic renal failure (CRF) is the most prevalent, worldwide public health problem of the
elderly population. The main cause of CRF is a damaged kidney. There are five stages of …

Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) have
significant cardiovascular morbidity and mortality that is in part due to the development of …

This guideline is written primarily for doctors and nurses working in dialysis units and related
areas of medicine in the UK, and is an update of a previous version written in 2009. It aims to …

The US health care system is in crisis. At stake are the quality of care for millions of
Americans and the financial well-being of individuals and employers squeezed by …

Hyperparathyroidism is due to increased activity of the parathyroid glands, either from an
intrinsic abnormal change altering excretion of parathyroid hormone (primary or tertiary …

Background. Cross-sectional and follow-up studies on end-stage renal disease patients
showed that arterial calcifications are associated with cardiovascular (CV) morbidity and are …

The kidneys play a pivotal role in the regulation of electrolyte and acid-base balance. With
progressive loss of kidney function, derangements in electrolytes and acid-base inevitably …